A record of what Marketsmith India Analysis said publicly, with the source. Not advice.
Pending — not yet graded
“Recommends buying Fortis Healthcare Limited within the range of ₹625–645, targeting a profit goal of ₹740 with a stop loss at ₹590, over a 2–3 month timeframe. This recommendation is made despite the broader market's negative bias.”
Marketsmith India Analysis’s track record (trackable calls only): 322 graded calls · 95% CI 22–32%
Fortis Healthcare LimitedBullishCalled 05 Mar 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.